PUBLISHER: The Business Research Company | PRODUCT CODE: 1938651
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938651
Farm animal drugs are critical medications developed for the treatment, prevention, and management of diseases in livestock, including cattle, pigs, and poultry. These medications play a vital role in ensuring animal health, enhancing productivity, and controlling the spread of infections. By promoting the well-being of livestock, farm animal drugs are essential for maintaining food safety and adhering to veterinary health standards in agricultural operations. Their use is crucial in supporting sustainable farming practices and ensuring a stable food supply.
The primary categories of farm animal drugs include anti-infective, parasiticides, anti-inflammatory agents, anesthetics, analgesics, hormones, and related products, among others. Anti-infective drugs are specifically designed to combat infections, either by preventing the spread of infectious agents or by eradicating the pathogen causing the infection. These medications are valuable in treating severe infections in various animals, including equine and small animals. Administration routes for farm animal drugs include oral, parenteral, topical, and other methods. These drugs are distributed through channels such as veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other outlets, catering to diverse animals, including livestock and equine species.
Tariffs have affected the farm animal drugs market by increasing the cost of imported active pharmaceutical ingredients, intermediates, and finished formulations, leading to higher drug prices and supply variability. Anti-infectives and parasiticides used in livestock-intensive regions such as Asia-Pacific, Latin America, and Europe are most impacted due to reliance on global supply chains. However, tariffs have also encouraged domestic drug manufacturing, localization of API production, and development of cost-efficient formulations, supporting long-term market stability and supply security.
The farm animal drugs market research report is one of a series of new reports from The Business Research Company that provides farm animal drugs market statistics, including farm animal drugs industry global market size, regional shares, competitors with a farm animal drugs market share, detailed farm animal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the farm animal drugs industry. This farm animal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The farm animal drugs market size has grown strongly in recent years. It will grow from $20.66 billion in 2025 to $21.96 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to growth in global livestock population, increasing prevalence of infectious animal diseases, rising demand for animal-derived food products, expansion of commercial farming operations, availability of established veterinary drug classes.
The farm animal drugs market size is expected to see strong growth in the next few years. It will grow to $28.88 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising emphasis on antimicrobial stewardship, increasing demand for high-quality animal protein, growth in veterinary healthcare infrastructure, stricter food safety and animal welfare regulations, innovation in livestock-specific drug formulations. Major trends in the forecast period include rising demand for preventive veterinary medications, increasing use of combination drug therapies, growing focus on food safety and residue compliance, expansion of therapeutics for intensive livestock farming, increasing adoption of prescription-based veterinary drugs.
The increasing meat consumption is expected to drive the growth of the farm animal drug market going forward. Meat consumption refers to the intake of animal flesh, typically derived from livestock such as chickens, pigs, and cattle. Farm animal drugs enhance growth, improve feed-to-meat conversion efficiency, and maintain the health of livestock. Rising meat consumption is being fueled by global population growth and urbanization, which increase demand for protein-rich foods and broaden access to meat in diets. The farm animal drug market supports this trend, as higher meat demand necessitates veterinary drugs to ensure livestock health, productivity, and meat quality. For instance, in July 2025, according to the Department for Environment, Food and Rural Affairs (Defra), a UK-based government department, total UK meat production reached 4,166 thousand tonnes in 2024, up from 4,059 thousand tonnes in 2023. Therefore, the increasing meat consumption is driving the growth of the farm animal drug market.
Major companies in the farm animal drug market are focusing on developing innovative solutions such as moxidectin injectable treatments for parasite control to maximize livestock productivity. Moxidectin injectable solutions are antiparasitic drugs administered in liquid form to treat and prevent internal and external parasites in cattle. For instance, in March 2023, Norbrook Laboratories Ltd., a UK-based pharmaceutical company, received FDA approval for Tauramox, the first generic moxidectin injectable solution for beef and non-lactating dairy cattle. Tauramox matches the concentration of moxidectin, is available over the counter, and comes in 250-ml and 500-ml bottles at 10 mg/ml, with a recommended dose of 1 ml per 110 lb of body weight.
In July 2024, MSD Animal Health, a US-based provider of veterinary pharmaceuticals, vaccines, and animal health technologies, acquired Elanco Animal Health Incorporated's aqua business for an undisclosed amount. This acquisition enabled Merck Animal Health to expand its product portfolio and strengthen its position in the global aquaculture market by incorporating a comprehensive range of fish health and sustainability solutions, including vaccines, anti-parasitic treatments, nutritional supplements, and related technologies. Elanco Animal Health Incorporated is a US-based provider of aquatic health products, including vaccines and treatments for both warm- and cold-water fish species.
Major companies operating in the farm animal drugs market are Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Ceva Sante Animale SA, Virbac SA, Huvepharma Inc, Phibro Animal Health Corporation, Dechra Pharmaceuticals plc, Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Neogen Corporation, Ouro Fino Saude Animal Participacoes SA, Eco Animal Health Ltd, Biogenesis Bago SA, Laboratorios Calier S.A., Laboratorios Syva S.A., Jurox Pty Ltd, Kepro B.V., Kyoritsu Seiyaku Corp., Merck Animal Health, Vetoquinol SA, Nippon Zenyaku Kogyo Co. Ltd., SeQuent Scientific Limited, Agrovet Market Animal Health, Orion Pharma Animal Health, Zydus Animal Health and Investments Limited
Asia-Pacific was the largest region in the farm animal drugs market in 2025. The regions covered in the farm animal drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the farm animal drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The farm animal drugs market consists of sales of endo-parasiticides, ectoparasitic ides, and endectocides. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Farm Animal Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses farm animal drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for farm animal drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The farm animal drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.